Mkts

Autolus Therapeutics plc

NASDAQ: AUTL
$1.28+0.02 (+1.59%)
As of Nov 6, 4:00 PM ET

Key statistics

Day range
1.271.32
52-week range
1.182.58
Today
Open1.28
Previous close1.28
Volume—
Valuation
Market cap367.29M
P/E ratio—
EPS (TTM)-1.05
Income & risk
Dividend / yield—
Beta2.49
Avg volume2.05M
Discussion

AUTL News

Stories mentioning AUTL from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue26,21824,28921,19420,9238,98229.000.000.00
Cost of Goods Sold24,56825,33028,64324,44517,95111,3870.000.00
Gross Profit1,650(1,041)(7,449)(3,522)(8,969)(11,358)0.000.00
Operating Expenses
Research & Development21,21035,63327,89227,43026,73430,83040,32336,612
Sales General & Admin39,95335,79236,28030,26529,53734,31327,33021,903
Total Operating Expenses
Operating Income (Loss)(59,513)(72,466)(71,621)(61,217)(65,240)(75,864)(67,876)(58,929)
Interest Income2,4693,2274,3825,2346,1377,4468,3209,656
Interest Expense11,12422,83610,520(6,829)10,143(30,835)10,68610,174
Other Expense100.00167.0084.00135.00129.00410.0054.0056.00
Pretax Income(70,735)(91,514)(78,586)(47,520)(67,936)(26,143)(82,072)(58,221)
Tax Provision863.00(1,182)532.00397.002,2251,46322.0051.00
Net Income (Loss)(71,598)(90,332)(79,118)(47,917)(70,161)(27,606)(82,094)(58,272)
Earnings Per Share (Basic)(0.27)(0.34)(0.30)(0.18)(0.26)(0.11)(0.31)(0.22)
Earnings Per Share (Diluted)(0.27)(0.34)(0.30)(0.18)(0.26)(0.11)(0.31)(0.22)
Weighted Average Shares Outstanding (Basic)266,143266,138266,141266,141266,127255,161266,085266,026
Weighted Average Shares Outstanding (Diluted)266,143266,138266,141266,141266,127255,161266,085266,026

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About AUTL

Autolus Therapeutics plc (NASDAQ: AUTL) is a stock listed on the Nasdaq Stock Market under the ticker symbol AUTL. It last traded at $1.28 (Nov 6, 2026, 4:00 PM ET), up 1.6% on the day. That gives Autolus Therapeutics a market capitalisation of $367.3M.

Over the past 52 weeks AUTL has traded between $1.18 and $2.58.

Revenue for the quarter ended Mar 31, 2026 was $26.2M; a net loss of $71.6M. Revenue was up 192% from $9.0M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$26.2M-$71.6M-273.1%
Dec 31, 2025$24.3M-$90.3M-371.9%
Sep 30, 2025$21.2M-$79.1M-373.3%
Jun 30, 2025$20.9M-$47.9M-229.0%

From Autolus Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…